CARDIO DIAGNOSTICS HOLDINGS (CDIO)

US14159C1036 - Common Stock

0.9738  -0.05 (-4.53%)

After market: 0.98 +0.01 (+0.64%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025 2026
Revenue
YoY % growth
17.07K372.3K
2,081.02%		535.5K
43.84%		25.5M
4,661.90%
EBITDA
YoY % growth
-600K-4.53M
-655.00%		-7.131M
-57.41%		N/AN/AN/A
EBIT
YoY % growth
-620K
-1.64%		-4.55M
-633.87%		-7.242M
-59.17%		-9.429M
-30.20%		-5.627M
40.32%		-11.475M
-103.92%
Operating Margin
N/AN/A-42,427.94%-2,532.74%-1,050.86%-45.00%
EPS
YoY % growth
N/AN/A-0.66
25.63%		-0.46
29.68%		-0.26
45.05%		N/A

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 24 Q1 / 25 Q2 / 25 Q3 / 25 Q4 / 25
EPS
Q2Q % growth		-0.11-0.06
69.40%		-0.06
-2.00%		-0.06
-2.00%		-0.06
45.45%
Revenue
Q2Q % growth		191.25K
3,501.69%		51K
220.15%		76.5K
872.05%		153K
2,225.23%		255K
33.33%
EBITDA
Q2Q % growth		N/AN/AN/AN/AN/A
EBIT
Q2Q % growth		-2.321M
-50.49%		-1.412M
66.05%		-1.406M
-9.60%		-1.427M
-1.28%		-1.384M
40.35%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2024
Q2Q % growth		 -0.06
62.50%		-0.100.0441.18%
Q2 2024
Q2Q % growth		 -0.06
84.62%		-0.110.0546.52%
Q1 2024
Q2Q % growth		 -0.20
-81.82%		-0.09-0.11-117.86%
Q4 2023
Q2Q % growth		 0.00
100.00%		-0.140.14100.00%
Q3 2023
Q2Q % growth		 -0.16
-900.00%		-0.280.1242.96%
Q2 2023
Q2Q % growth		 -0.39 -0.19-0.20-106.68%
Q1 2023
Q2Q % growth		 -0.11 -0.180.0740.09%
Q4 2022
Q2Q % growth		 -0.09 -0.090.001.96%
Q3 2022
Q2Q % growth		 0.02 -0.670.69102.97%
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2024
Q2Q % growth		 6.58K
-34.40%		107.1K-100.52K-93.86%
Q2 2024
Q2Q % growth		 7.87K
293.50%		114.75K-106.88K-93.14%
Q1 2024
Q2Q % growth		 15.93K 51K-35.07K-68.76%
Q4 2023
Q2Q % growth		 5.31K
458.95%		255K-249.69K-97.92%
Q3 2023
Q2Q % growth		 10.03K 127.5K-117.47K-92.13%
Q2 2023
Q2Q % growth		 2K 61.2K-59.2K-96.73%
Q1 2023
Q2Q % growth		 30.6K-30.6K-100.00%
Q4 2022
Q2Q % growth		 950 408K-407.05K-99.77%
Q3 2022
Q2Q % growth		 102K-102K-100.00%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% 12% 0% 0%
Revenue0% -37.5% -0.54% -38.71%